A potent and selective CXCR2 antagonist improves neuroimmune dysregulation through the inhibition of NF-κB and notch inflammatory signaling in the BTBR mouse model of autism

Authors :: Hatun A. Alomar
Mushtaq A. Ansari
Ahmed Nadeem
Sabry M. Attia
Saleh A. Bakheet
Haneen A. Al-Mazroua
Marwa H. Hussein
Saleh A. Alqarni
Sheikh F. Ahmad
Source :: Journal of Neuroimmunology. 377:578069
Publication Year :: 2023
Publisher :: Elsevier BV, 2023.

Subjects :: Neurology
Immunology
Immunology and Allergy
Neurology (clinical)

Full Text Access

Tools